|
1
|
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
|
J Hypertens
|
2007
|
20.09
|
|
2
|
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
|
J Hypertens
|
2013
|
18.17
|
|
3
|
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2013
|
12.73
|
|
4
|
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
|
Eur Heart J
|
2007
|
9.43
|
|
5
|
European Society of Hypertension position paper on ambulatory blood pressure monitoring.
|
J Hypertens
|
2013
|
4.28
|
|
6
|
Working Group on Blood Pressure Monitoring of the European Society of Hypertension International Protocol for validation of blood pressure measuring devices in adults.
|
Blood Press Monit
|
2002
|
4.02
|
|
7
|
European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring.
|
J Hypertens
|
2008
|
3.32
|
|
8
|
Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers?
|
J Hypertens
|
2003
|
2.72
|
|
9
|
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension.
|
Blood Press
|
2013
|
2.62
|
|
10
|
Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications.
|
Am J Hypertens
|
2002
|
2.15
|
|
11
|
The vasodilatory response of skin microcirculation to local heating is subject to desensitization.
|
Microcirculation
|
2009
|
2.02
|
|
12
|
Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo.
|
Free Radic Biol Med
|
2006
|
1.99
|
|
13
|
European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.
|
J Hypertens
|
2014
|
1.58
|
|
14
|
Angiotensin receptor blockers: therapeutic targets and cardiovascular protection.
|
Blood Press
|
2005
|
1.49
|
|
15
|
Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression.
|
J Hypertens
|
2012
|
1.45
|
|
16
|
Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum?
|
J Hypertens
|
2012
|
1.41
|
|
17
|
Sepsis up-regulates the expression of connexin 40 in rat aortic endothelium.
|
Crit Care Med
|
2005
|
1.40
|
|
18
|
The management of the type 2 diabetic patient with hypertension - too late and too little: suggested improvements.
|
Blood Press
|
2008
|
1.40
|
|
19
|
Eligibility to treatment and economic effect of the implementation of the new U.S. or European Society of Hypertension/European Society of Cardiology hypertension guidelines.
|
J Hypertens
|
2015
|
1.40
|
|
20
|
Assessment of coronary vasoreactivity by multidetector computed tomography: feasibility study with rubidium-82 cardiac positron emission tomography.
|
Circ J
|
2011
|
1.40
|
|
21
|
Pulse wave analysis of aortic pressure: diastole should also be considered.
|
J Hypertens
|
2013
|
1.39
|
|
22
|
Influence of high cardiovascular risk in asymptomatic people on the duration and cost of sick leave: results of the ICARIA study.
|
Eur Heart J
|
2013
|
1.37
|
|
23
|
Monitoring one-year compliance to antihypertension medication in the Seychelles.
|
Bull World Health Organ
|
2002
|
1.30
|
|
24
|
Hypertension and microvascular remodelling.
|
Cardiovasc Res
|
2008
|
1.26
|
|
25
|
Hypertension: a disease of the microcirculation?
|
Hypertension
|
2006
|
1.21
|
|
26
|
Oxidants positively or negatively regulate nuclear factor kappaB in a context-dependent manner.
|
J Biol Chem
|
2010
|
1.19
|
|
27
|
Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines.
|
J Biol Chem
|
2005
|
1.13
|
|
28
|
Ambulatory blood pressure monitoring to assess cardiovascular risk in women.
|
Hypertension
|
2011
|
1.11
|
|
29
|
Evaluation of an online, case-based interactive approach to teaching pathophysiology.
|
Med Teach
|
2008
|
1.10
|
|
30
|
The macrocirculation and microcirculation of hypertension.
|
Curr Hypertens Rep
|
2009
|
1.07
|
|
31
|
Dose-dependent vasodilatory effects of acetylcholine and local warming on skin microcirculation.
|
J Cardiovasc Pharmacol
|
2004
|
0.99
|
|
32
|
Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo.
|
Cardiovasc Res
|
2010
|
0.98
|
|
33
|
Homocysteine induces cell death in H9C2 cardiomyocytes through the generation of peroxynitrite.
|
Biochem Biophys Res Commun
|
2007
|
0.98
|
|
34
|
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
|
J Hypertens
|
2009
|
0.96
|
|
35
|
Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.
|
J Hypertens
|
2004
|
0.96
|
|
36
|
Blunted vasodilatory responses in the cutaneous microcirculation of cigarette smokers.
|
Am Heart J
|
2002
|
0.95
|
|
37
|
Endotoxin impairs cardiac hemodynamics by affecting loading conditions but not by reducing cardiac inotropism.
|
Am J Physiol Heart Circ Physiol
|
2010
|
0.95
|
|
38
|
Acute inflammation decreases the expression of connexin 40 in mouse lung.
|
Shock
|
2007
|
0.94
|
|
39
|
Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion.
|
Proc Natl Acad Sci U S A
|
2006
|
0.92
|
|
40
|
Acetylcholine-induced vasodilation and reactive hyperemia are not affected by acute cyclo-oxygenase inhibition in human skin.
|
Microcirculation
|
2004
|
0.92
|
|
41
|
[ESH/ESC 2007 Guidelines for the management of arterial hypertension].
|
Rev Esp Cardiol
|
2007
|
0.90
|
|
42
|
Endurance training enhances vasodilation induced by nitric oxide in human skin.
|
J Invest Dermatol
|
2003
|
0.90
|
|
43
|
The past, present and future of renin-angiotensin aldosterone system inhibition.
|
Int J Cardiol
|
2012
|
0.90
|
|
44
|
Bacterial flagellin elicits widespread innate immune defense mechanisms, apoptotic signaling, and a sepsis-like systemic inflammatory response in mice.
|
Crit Care
|
2010
|
0.89
|
|
45
|
Prevention of microalbuminuria in patients with type 2 diabetes: what do we know?
|
J Clin Hypertens (Greenwich)
|
2010
|
0.88
|
|
46
|
Reactive rise in blood pressure upon cuff inflation: cuff inflation at the arm causes a greater rise in pressure than at the wrist in hypertensive patients.
|
Blood Press Monit
|
2007
|
0.88
|
|
47
|
Bacterial flagellin triggers cardiac innate immune responses and acute contractile dysfunction.
|
PLoS One
|
2010
|
0.88
|
|
48
|
Whole-body vibration training elevates creatine kinase levels in sedentary subjects.
|
Swiss Med Wkly
|
2011
|
0.88
|
|
49
|
Local heating of human skin causes hyperemia without mediation by muscarinic cholinergic receptors or prostanoids.
|
J Appl Physiol (1985)
|
2004
|
0.87
|
|
50
|
Discrepancies between office and ambulatory blood pressure: clinical implications.
|
Am J Med
|
2009
|
0.86
|
|
51
|
Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes.
|
Vasc Health Risk Manag
|
2008
|
0.86
|
|
52
|
Major impact of body position on arterial stiffness indices derived from radial applanation tonometry in pregnant and nonpregnant women.
|
J Hypertens
|
2012
|
0.85
|
|
53
|
Functional late outgrowth endothelial progenitors isolated from peripheral blood of burned patients.
|
Burns
|
2012
|
0.85
|
|
54
|
Differential persistence with initial antihypertensive therapies: a clue for understanding the needs of hypertensive patients.
|
J Hypertens
|
2006
|
0.82
|
|
55
|
Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: the GEMS project.
|
Angiology
|
2008
|
0.82
|
|
56
|
Determinants of persistence in hypertensive patients treated with irbesartan: results of a postmarketing survey.
|
BMC Cardiovasc Disord
|
2005
|
0.82
|
|
57
|
Acute endotoxemia inhibits microvascular nitric oxide-dependent vasodilation in humans.
|
Shock
|
2011
|
0.82
|
|
58
|
Peroxynitrite is a key mediator of the cardioprotection afforded by ischemic postconditioning in vivo.
|
PLoS One
|
2013
|
0.81
|
|
59
|
Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE).
|
Swiss Med Wkly
|
2011
|
0.81
|
|
60
|
ACE inhibition and cardiovascular mortality and morbidity in essential hypertension: the end of the search or a need for further investigations?
|
Am J Hypertens
|
2002
|
0.81
|
|
61
|
Therapeutic strategies to improve control of hypertension.
|
J Hypertens
|
2013
|
0.81
|
|
62
|
Endothelium-dependent vasodilation in the skin microcirculation of patients with septic shock.
|
Shock
|
2003
|
0.81
|
|
63
|
Preserved capillary density of dorsal finger skin in treated hypertensive patients with or without type 2 diabetes.
|
Microcirculation
|
2012
|
0.79
|
|
64
|
Concomitant calcium entry blockade and inhibition of the renin-angiotensin system: a rational and effective means for treating hypertension.
|
J Renin Angiotensin Aldosterone Syst
|
2008
|
0.79
|
|
65
|
[Hypertension: early detection of target organ damage].
|
Rev Med Suisse
|
2007
|
0.79
|
|
66
|
Haemodialysis acutely reduces the plasma levels of ADMA without reversing impaired NO-dependent vasodilation.
|
Clin Sci (Lond)
|
2009
|
0.79
|
|
67
|
Brain natriuretic peptide is able to stimulate cardiac progenitor cell proliferation and differentiation in murine hearts after birth.
|
Basic Res Cardiol
|
2014
|
0.78
|
|
68
|
Efficacy and safety of fluvastatin in hyperlipidemic protease inhibitor-treated HIV-infected patients.
|
AIDS
|
2002
|
0.78
|
|
69
|
Moderate hypercapnia exerts beneficial effects on splanchnic energy metabolism during endotoxemia.
|
Intensive Care Med
|
2009
|
0.78
|
|
70
|
Bilateral symmetry of radial pulse in high-level tennis players: implications for the validity of central aortic pulse wave analysis.
|
J Hypertens
|
2009
|
0.78
|
|
71
|
NPY Y1 receptor is not involved in the hemodynamic response to an acute cold pressor test in mice.
|
Peptides
|
2007
|
0.78
|
|
72
|
Targeting systolic blood pressure: the key to controlling combined systolic/diastolic hypertension.
|
Am J Hypertens
|
2006
|
0.78
|
|
73
|
Critical review of cancer risk associated with angiotensin receptor blocker therapy.
|
Vasc Health Risk Manag
|
2011
|
0.77
|
|
74
|
Profound impact of uncomplicated pregnancy on diastolic, but not systolic pulse contour of aortic pressure.
|
J Hypertens
|
2006
|
0.77
|
|
75
|
Hypertension: which aspects of hypertension should we impact on and how?
|
J Hypertens Suppl
|
2006
|
0.77
|
|
76
|
No major impact of skin aging on the response of skin blood flow to a submaximal local thermal stimulus.
|
Microcirculation
|
2014
|
0.76
|
|
77
|
Brachial or wrist blood pressure in obese patients: which is the best?
|
Blood Press Monit
|
2008
|
0.76
|
|
78
|
Should hypertensive patients take vitamin D?
|
Curr Hypertens Rep
|
2012
|
0.76
|
|
79
|
Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial.
|
Vasc Health Risk Manag
|
2007
|
0.76
|
|
80
|
Ambulatory and home blood pressure monitoring in people with chronic kidney disease. Time to abandon clinic blood pressure measurements?
|
Curr Opin Nephrol Hypertens
|
2015
|
0.75
|
|
81
|
What has been learned from electronic monitoring of compliance with antihypertensive medications?
|
J Hypertens
|
2004
|
0.75
|
|
82
|
Twenty-four hour blood pressure monitoring: in ambulatory conditions or in-hospital?
|
J Hypertens
|
2006
|
0.75
|
|
83
|
A community-based intervention program to effectively treat hypertension in developing countries.
|
J Hypertens
|
2013
|
0.75
|
|
84
|
The need for hospitalization still represents a major burden for hypertensive patients and healthcare systems.
|
J Hypertens
|
2013
|
0.75
|
|
85
|
Plasma renin levels: the lower the better in terms of cardiovascular risk?
|
Eur Heart J
|
2012
|
0.75
|
|
86
|
Impact of depression on drug intake in hypertensive patients.
|
J Hypertens
|
2010
|
0.75
|
|
87
|
[Treating arterial hypertension: do not lower your attention!].
|
Rev Med Suisse
|
2008
|
0.75
|
|
88
|
Measurement with an automated oscillometric wrist device with position sensor leads to lower values than measurements obtained with an automated oscillometric arm device from the same manufacturer in elderly persons.
|
Blood Press Monit
|
2014
|
0.75
|
|
89
|
Highlights from International Congress : The XI Forum on the Renin-Angiotensin System, Capri, Italy, 11-12 April, 2008.
|
High Blood Press Cardiovasc Prev
|
2008
|
0.75
|
|
90
|
[Renal denervation in resistant hypertension: proposal for a common multidisciplinary attitude].
|
Rev Med Suisse
|
2012
|
0.75
|
|
91
|
[Angiotensin II antagonists and cancer: the straw fire is extinguished].
|
Praxis (Bern 1994)
|
2011
|
0.75
|
|
92
|
[Drug industry influence on hypertension treatment trials].
|
Rev Med Suisse
|
2005
|
0.75
|
|
93
|
Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus.
|
Swiss Med Wkly
|
2014
|
0.75
|
|
94
|
[Whole-body vibration training: fact or fiction?].
|
Rev Med Suisse
|
2008
|
0.75
|
|
95
|
The hemodynamics of septic shock: a historical perspective.
|
Curr Vasc Pharmacol
|
2013
|
0.75
|
|
96
|
No implication of thromboxane prostanoid receptors in reactive hyperemia of skin and skeletal muscle in human forearm.
|
J Cardiovasc Pharmacol
|
2013
|
0.75
|
|
97
|
[Hypertension and vitamin D: not again].
|
Rev Med Suisse
|
2011
|
0.75
|
|
98
|
[Hypertension: new European guidelines have arrived! BP <140/90 mmHg for all].
|
Rev Med Suisse
|
2013
|
0.75
|
|
99
|
[Again and again...new recommendations for the management of hypertension].
|
Rev Med Suisse
|
2007
|
0.75
|
|
100
|
Discordant prevalence of hypertension using two different automated blood pressure measurement devices: a population-based study in Dar es Salaam (Tanzania).
|
Blood Press Monit
|
2004
|
0.75
|
|
101
|
[Recent updates for high risk cardiovascular patient and "very" recent updates for the "very" elderly].
|
Praxis (Bern 1994)
|
2008
|
0.75
|
|
102
|
Desensitization of thermal hyperemia in the skin is reproducible.
|
Microcirculation
|
2012
|
0.75
|
|
103
|
[Atherosclerotic renal stenosis: indications for revascularisation].
|
Rev Med Suisse
|
2008
|
0.75
|
|
104
|
[Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment].
|
Therapie
|
2003
|
0.75
|